Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Artificial Intelligence UCITS ETF 02.01.2026 FTAI IE000YIQZ0H6 100,002.00 USD 2,384,553.68 23.845  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Max Buffer UCITS ETF- June 02.01.2026 MJUN LN IE000CO3P697 150,002.00 USD 3,716,508.24 24.776  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest Nasdaq-100 Moderate Buffer UCITS ETF - December 02.01.2026 QDEC.LN IE000GAKWFA7 300,002.00 USD 6,819,497.07 22.732  ...
-

Clinical Trial Supplies Company Evaluation Report 2025: Market Led by Thermo Fisher Scientific, Sharp Services, and Parexel Through End-to-End Capabilities Span Packaging, Logistics, Trial Management - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Clinical Trial Supplies - Company Evaluation Report, 2025" report has been added to ResearchAndMarkets.com's offering. The Clinical Trial Supplies Companies Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Clinical Trial Supplies. This quadrant offers a detailed evaluation of key market players, technological advancements, product innovations, and emerging trends shaping the industry. The analyst's '360 Quadra...
-

Europe Voice/Vocal Biomarker Market Analysis and Forecast Report 2025-2035, Profiles of Key Players - auddering, EVOCAL Health, VoiceMed Italia, and Zana Technologies - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Europe Voice/Vocal Biomarker Market: Focus on Platform Type, Application, Indication, End User, and Country Analysis - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering. The Europe voice/vocal biomarker market is projected to reach $1.69 billion by 2035 from $335.2 million in 2024, growing at a CAGR of 16% during the forecast period 2025-2035. An emerging market within the larger digital health ecosystem is the European vo...
-

U-Haul Growth Index: Texas Back on Top as No. 1 Growth State of 2025

PHOENIX--(BUSINESS WIRE)--Texas and Florida lead the list of in-migration states on the U-Haul® Growth Index analyzing one-way customer transactions during 2025, while California ranks last with the greatest out-migration number for the sixth consecutive year. Texas reclaims the title of No. 1 U-Haul growth state for the seventh time in 10 years. It climbs one spot from its previous ranking behind South Carolina, which slides four spots after being the leading growth state for 2024. Florida, No...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones International Internet UCITS ETF 02.01.2026 FDNI.LN IE00BT9PVG14 400,002.00 USD 9,224,759.31 23.062  ...
-

NeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

FORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics will participate in the upcoming 44th Annual J.P. Morgan Healthcare Conference in San Francisco....
-

SkyWater Technology to Present at the 28th Annual Needham Growth Conference

BLOOMINGTON, Minn.--(BUSINESS WIRE)--SkyWater Technology (NASDAQ: SKYT), the largest U.S.-based, pure-play semiconductor foundry, today announced that management is scheduled to participate in the 28th Annual Needham Growth Conference, taking place next week at the Lotte New York Palace. SkyWater’s fireside chat will be webcast live on Wednesday, January 14th at 1:30pm EST at the following link: https://wsw.com/webcast/needham148/skyt/2305989. The presentation material utilized during the confe...
-

Herbalife to Announce Fourth Quarter and Full-Year 2025 Results on February 18

LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, will release its fourth quarter and full-year 2025 financial results after the close of trading on the NYSE on Wednesday, February 18, 2026. On the same day, at 5:30 p.m. ET (2:30 p.m. PT), Herbalife’s senior management team will host an audio webcast and conference call to discuss its recent financial results. The audio webcast will be available at the following link: https:...